The standard chemotherapy treatments currently offered for mesothelioma patients include cisplatin and pemetrexed or a combination of cisplatin and gemcitabine. Recently though, scientists in Greece have tested the effectiveness of combining gemcitabine and docetaxel for the treatment of malignant pleural mesothelioma.
Pleural mesothelioma is a rare cancer that develops in the lining of the lungs. The primary cause of this illness is exposure to asbestos and those who contract this cancer have often worked in industries ranging from shipyards to construction sites to power and chemical plants.
Even though someone may have been exposed to asbestos several decades ago, they are still at risk for developing mesothelioma as the latency period for symptoms to arise can reach 50 years. Those who have previously worked in industrial settings are encouraged to seek routine medical checkups for signs of asbestos exposure.
More
Pleural mesothelioma is a rare cancer that develops in the lining of the lungs. The primary cause of this illness is exposure to asbestos and those who contract this cancer have often worked in industries ranging from shipyards to construction sites to power and chemical plants.
Even though someone may have been exposed to asbestos several decades ago, they are still at risk for developing mesothelioma as the latency period for symptoms to arise can reach 50 years. Those who have previously worked in industrial settings are encouraged to seek routine medical checkups for signs of asbestos exposure.
More
Comments